Diabetic nephropathy and risk factors for peripheral artery disease in Chinese with type 2 diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 58, Issue 4, 2009, Pages 504-509

  Hsieh, Ming Chia ^a   Tien, Kai Jen ^a   Perng, Daw Shyong ^b   Hsiao, Jeng Yueh ^a   Chang, Shun Jen ^c   Liang, Hui Ting ^a   Chen, Hung Chun ^a   Tu, Shih Te ^d  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

^c Department of Otorhinolaryngology Head and Neck Surgery   (Taiwan)

^d CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CHOLESTEROL; CREATININE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CHINESE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HIGH RISK POPULATION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE;

AGED; CHINA; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; RISK FACTORS;

EID: 62349125521     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.11.008     Document Type: Article

References (50)

1. Cheng S.W., et al. Epidemiology of atherosclerotic peripheral arterial occlusive disease in Hong Kong. World J Surg 23 (1999) 202-206
2. Al Zahrani H.A., et al. The distribution of peripheral arterial disease in a defined population of elderly high-risk Saudi patients. Int Angiol 16 (1997) 123-128
3. Novo S., et al. Prevalence of risk factors in patients with peripheral arterial disease. A clinical and epidemiological evaluation. Int Angiol 11 (1992) 218-229
4. Fowkes F.G., et al. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol 135 (1992) 331-340
5. Epidemiology of lower extremity amputation in centres in Europe, North America and East Asia. The Global Lower Extremity Amputation Study Group. Br J Surg 87 (2000) 328-337
6. Tseng C.H., et al. Mortality in diabetic patients after lower extremity amputations. J Formos Med Assoc 93 (1994) 842-848
7. Rhee S.Y., et al. Multi-country study on the prevalence and clinical features of peripheral arterial disease in Asian type 2 diabetes patients at high risk of atherosclerosis. Diabetes Res Clin Pract 76 (2007) 82-92
8. Hsieh M.C., et al. Chronic kidney disease as a risk factor for coronary artery disease in Chinese with type 2 diabetes. Am J Nephrol 28 (2008) 317-323
9. Tseng C.H. Sex difference in the distribution of atherosclerotic risk factors and their association with peripheral arterial disease in Taiwanese type 2 diabetic patients. Circ J 71 (2007) 1131-1136
10. Crouse III J.R. Gender, lipoproteins, diet, and cardiovascular risk. Sauce for the goose may not be sauce for the gander. Lancet 1 (1989) 318-320
11. Cheng S.W., et al. Survival in patients with chronic lower extremity ischemia: a risk factor analysis. Ann Vasc Surg 14 (2000) 158-165
12. National Institutes of Health, and National Institute of Diabetes and Digestive and Kidney Diseases. US renal data system (1998), USRDS
13. O'Hare A.M., et al. High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the National Health and Nutrition Examination Survey 1999-2000. Circulation 109 (2004) 320-323
14. Leskinen Y., et al. The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: requirements for diagnostics. Am J Kidney Dis 40 (2002) 472-479
15. O'Hare A.M., et al. Renal insufficiency and the risk of lower extremity peripheral arterial disease: results from the Heart and Estrogen/Progestin Replacement Study (HERS). J Am Soc Nephrol 15 (2004) 1046-1051
16. Wattanakit K., et al. Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study. J Am Soc Nephrol 18 (2007) 629-636
17. Chi Z.S., et al. Vascular disease prevalence in diabetic patients in China: standardised comparison with the 14 centres in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 44 (2001) S82-S86
18. Dieter R.S., et al. The significance of lower extremity peripheral arterial disease. Clin Cardiol 25 (2002) 3-10
19. Levey A.S., et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139 (2003) 137-147
20. Thomas G.N., et al. Peripheral vascular disease in type 2 diabetic Chinese patients: associations with metabolic indices, concomitant vascular disease and genetic factors. Diabet Med 20 (2003) 988-995
21. Hasimu B., et al. Ankle brachial index as a marker of atherosclerosis in Chinese patients with high cardiovascular risk. Hypertens Res 29 (2006) 23-28
22. Wattanakit K., et al. Albuminuria and peripheral arterial disease: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis (2008)
23. Kallio M., et al. Development of new peripheral arterial occlusive disease in patients with type 2 diabetes during a mean follow-up of 11 years. Diabetes Care 26 (2003) 1241-1245
24. Tseng C.H., et al. The association between urinary albumin excretion and ankle-brachial index in elderly Taiwanese patients with type 2 diabetes mellitus. Age Ageing 37 (2008) 77-82
25. Baigent C., Burbury K., and Wheeler D. Premature cardiovascular disease in chronic renal failure. Lancet 356 (2000) 147-152
26. Gerstein H.C., et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286 (2001) 421-426
27. Katsilambros N.L., et al. Risk factors for lower extremity arterial disease in non-insulin-dependent diabetic persons. Diabet Med 13 (1996) 243-246
28. Allison M.A., et al. The effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 48 (2006) 1190-1197
29. Tseng C.H. Prevalence and risk factors of peripheral arterial obstructive disease in Taiwanese type 2 diabetic patients. Angiology 54 (2003) 331-338
30. Li J., et al. Risk factors of peripheral arterial disease and relationship between low ankle-brachial index and mortality from all-cause and cardiovascular disease in Chinese patients with type 2 diabetes. Circ J 71 (2007) 377-381
31. Premalatha G., et al. Prevalence and risk factors of peripheral vascular disease in a selected South Indian population: the Chennai Urban Population Study. Diabetes Care 23 (2000) 1295-1300
32. Meijer W.T., et al. Determinants of peripheral arterial disease in the elderly: the Rotterdam study. Arch Intern Med 160 (2000) 2934-2938
33. Meigs J.B., et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 91 (2006) 2906-2912
34. Adler A.I., et al. UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care 25 (2002) 894-899
35. Sritara P., et al. Prevalence and risk factors of peripheral arterial disease in a selected Thai population. Angiology 58 (2007) 572-578
36. Stump C.S., et al. The metabolic syndrome: role of skeletal muscle metabolism. Ann Med 38 (2006) 389-402
37. Imbeault P., et al. Weight loss-induced rise in plasma pollutant is associated with reduced skeletal muscle oxidative capacity. Am J Physiol Endocrinol Metab 282 (2002) E574-E579
38. Pecoits-Filho R., et al. Genetic approaches in the clinical investigation of complex disorders: malnutrition, inflammation, and atherosclerosis (MIA) as a prototype. Kidney Int Suppl (2003) S162-S167
39. Barzilay J.I., et al. Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders: the Cardiovascular Health Study. Diabetes Care 24 (2001) 1233-1239
40. Orchard T.J., and Strandness Jr. D.E. Assessment of peripheral vascular disease in diabetes. Report and recommendations of an international workshop sponsored by the American Diabetes Association and the American Heart Association 18-20 September 1992, New Orleans, Louisiana. Circulation 88 (1993) 819-828
41. Resnick H.E., et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation 109 Suppl 2 (2004) 733-739
42. Pan W.H., and Chiang B.N. Plasma lipid profiles and epidemiology of atherosclerotic diseases in Taiwan-a unique experience. Atherosclerosis 118 (1995) 285-295
43. Tseng C.H., et al. Independent association between triglycerides and coronary artery disease in Taiwanese type 2 diabetic patients. Int J Cardiol 111 (2006) 80-85
44. Peripheral arterial disease in people with diabetes. Diabetes Care 26 (2003) 3333-3341
45. Bernstein E.F., and Fronek A. Current status of noninvasive tests in the diagnosis of peripheral arterial disease. Surg Clin North Am 62 (1982) 473-487
46. Lamarche B., et al. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec cardiovascular study. Circulation 94 (1996) 273-278
47. Walldius G., et al. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358 (2001) 2026-2033
48. Ridker P.M., et al. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 294 (2005) 326-333
49. van der Steeg W.A., et al. Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: a case-control analysis in EPIC-Norfolk. Ann Intern Med 146 (2007) 640-648
50. Ingelsson E., et al. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA 298 (2007) 776-785